Clinical Trial Update: Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the early bactericidal activity of SQ109 in adults with pulmonary tuberculosis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• SQ109 (SQ109)

Snippet

Sponsor: Michael Hoelscher | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: COMPLETED